https://www.aigom.it/wp-content/uploads/2024/04/art.9.4.png821663Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-04-05 07:37:332024-04-11 07:58:10ENFORTUMAB VEDOTIN AND PEMBROLIZUMAB IN UNTREATED ADVANCED. UROTHELIAL CANCER
https://www.aigom.it/wp-content/uploads/2024/03/lan.articolo.png911927Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-03-22 07:12:532024-03-22 07:18:33NANOLIPOSOMAL IRINOTECAN WITH FLUOROURACIL AND FOLINIC ACID IN METASTATIC PANCREATIC CANCER AFTER PREVIOUS GEMCITABINE-BASED THERAPY (NAPOLI-1): A GLOBAL, RANDOMISED, OPEN-LABEL, PHASE 3 TRIAL
https://www.aigom.it/wp-content/uploads/2024/03/jco8.3.png869923Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-03-08 08:09:282024-03-08 08:09:28EFFECT OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY ON CYTOREDUCTIVE SURGERY IN GASTRIC CANCER WITH SYNCHRONOUS PERITONEAL METASTASES: THE PHASE III GASTRIPEC-I TRIAL
https://www.aigom.it/wp-content/uploads/2024/02/ARTICOLO-15feb.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-15 15:00:492024-02-15 15:00:49ATEZOLIZUMAB CON O SENZA RADIOTERAPIA PER IL CARCINOMA SQUAMOSO AVANZATO DEL PENE (STUDIO PERICLES): TRIAL DI FASE II
https://www.aigom.it/wp-content/uploads/2024/02/ARTICOLO-9febb.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-09 13:42:322024-02-09 13:43:30STUDIO KATHERINE: T-DM1 adiuvante vs trastuzumab per EBC HER2+ con malattia residua dopo terapia neoadiuvante (chemioterapia e anti-HER2). Analisi finale della IDFS e seconda interim analisi della OS.
https://www.aigom.it/wp-content/uploads/2024/02/ARTICOLO-5feb.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-05 09:02:192024-02-05 09:02:19PROPHYLACTIC RADIATION THERAPHY VERSUS STANDARD OF CARE FOR PATIENTS WITH HIGH-RISK ASYMPTOMATIC BONE METASTASIS: A MULTICENTER, RANDOMIZED PHASE II CLINICAL TRIAL.
https://www.aigom.it/wp-content/uploads/2024/01/CRITICAL-REVIEWS.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-01-26 10:33:532024-01-26 10:33:53PRACTICAL GUIDELINES FOR MOLECULAR TESTING OF CHOLANGIOCARCINOMA IN CLINICAL PRACTICE: ITALIAN EXPERTS’ POSITION PAPER.
https://www.aigom.it/wp-content/uploads/2024/01/ARTICOLO-1801.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-01-18 14:53:452024-01-18 14:53:45CARDIOVASCULAR DISEASE IN TESTICULAR CANCER SURVIVORS: IDENTIFICATION OF RISK FACTORS AND IMPACT ON QUALITY OF LIFE.
